|
1.IntroductionSerum albumin is the most abundant protein in the blood circulation and is well-known as transport protein. The most important function of albumins is transportation of various organic and inorganic compounds including drugs.1–4 Serum albumin interaction with various drugs plays a major role in estimation of the small molecules distribution, elimination, and transport in biological systems. Being familiar with the molecular basis of drug-albumin binding is crucial in designing new therapeutic agents for improvement of drug activity. Therefore, albumin–drug binding study is important and may influence properties of typical drugs. Due to low cost, medical care, availability, and binding properties, bovine serum albumin (BSA) usually is selected for investigation of drug binding capability.5–7 Rifampicin (Fig. 1) is an example of antibiotics used for treatment of pulmonary tuberculosis.8,9 Despite the broad pharmacological application of rifampicin, its mechanism of action and effects on serum albumin is poorly understood and investigated using surface plasmon resonance (SPR). Therefore, study of BSA interaction with rifampicin could be a challenging issue and the development of a reliable analytical method, such as SPR that allows the measurement of rifampicin–albumin interaction kinetics, would be of great value. SPR is a sensitive label-free technique that detects the changes in refractive index at surfaces of metals. It can be used for study of biomolecular interactions with various drugs and ligands with high sensitivity.10–12 Label free, real-time and both qualitative and quantitative detection are examples of SPR advantages compared to other techniques. In addition, determination of kinetic constants and thermodynamic parameters is possible using this technique.12–14 To the best of our knowledge, interaction of rifampicin with BSA has not been reported using the SPR technique. Owing to the extensive application of rifampicin, investigation on BSA interaction needs to be addressed. Therefore, in the current study, we investigated the binding properties of rifampicin with BSA using SPR method and molecular docking analysis. 2.Materials and Methods2.1.MaterialsRifampicin was purchased from Sigma-Aldrich (Steinheim, Germany). Phosphate-buffered saline (PBS) solution, acetate buffer, BSA, ethanolamine-HCl, N-hydroxysuccinimide (NHS), and N-ethyl-N-(3-diethylaminopropyl) carbodiimide (EDC) were purchased from Merck (Darmstadt, Germany). Carboxymethyl dextran (CMD) low-density-modified gold surfaces chip was prepared from Bionavis Company (Tampere-region, Finland). 2.2.ApparatusAll kinetic parameters were recorded with dual-flow channels SPR device (MP-SPR Navi 210A, BioNavis Ltd., Tampere-region, Finland). 2.3.Bovine Serum Albumin ImmobilizationAfter putting a CMD sensor chip on SPR instrument, the whole device is rinsed with acetate buffer. As soon as reaching steady baseline in sensorgram, the chip surface cleaned with NaCl (2 M) and NaOH (0.1 M) by injecting them to both channels for 3 min. To activate the chip surface EDC: NHS 1:1 (NHS 0.05 M + EDC 0.2 M) solution injected to the sensor chip for 7 min. For immobilization of BSA, the BSA solution injected () to channel 1, for 10 min and acetate buffer injected (running buffer) to channel 2 (reference channel). Finally, ethanolamine-HCl (1 M, pH 8.5) was injected for blocking the remaining activated surface groups. All of the injection processes were performed with flow rate of . 2.4.Kinetic Parameters of Bovine Serum Albumin Interaction with RifampicinRifampicin solution in PBS buffer at pH 7.4 was injected using a flow rate of for 3 min at various concentrations (1 to ). Both flow cells were used for sample injection and due to BSA immobilization at one flow cells, the flow cell without any BSA was used as reference. Rapid dissociation of rifampicin from BSA surface omits the need for regeneration process. To estimate the affinity and kinetic of the BSA interaction with rifampicin, Trace Drawer™ for SPR Navi™ was used. Before calculations in Trace Drawer, data are extracted with SPR Navi™ Data viewer software. 2.5.Thermodynamic AnalysisThe effect of temperature on binding of rifampicin to BSA was studied to estimate the thermodynamic parameters of rifampicin–BSA complex formation. Therefore, SPR measurements were investigated at four different temperatures (298, 303, 308, and 313 K). 2.6.Molecular Docking SimulationThe docking study of BSA with rifampicin was performed by the open-source windows version of Auto Dock Vina 1.1.2 software. Auto Dock Vina not only improves the accuracy of molecular docking between the ligand and receptor but also increases the speed of dock running.15 For study of the molecular interaction of BSA with rifampicin by in silico simulation, the x-ray structure of BSA (PDB ID code4F5S, 2.47 Å resolutions) was selected from the Research Collaboratory for Structural Bioinformatics protein data bank. The rifampicin molecular structure was prepared by drawing the two-dimensional chemical structure by Chem Draw Ultra 10.0 software and then for molecular energy optimization, the HyperChem 8.0.8 software was selected. Molecular structure optimization of rifampicin was done in two steps: at first the MM+ molecular mechanics was performed and after completed this step the AM1 semiempirical procedures was executed. To minimize rifampicin structure, the Fletcher–Reeves algorithm was selected in both optimization processes.16 For the docking study, the extracrystallographic structure, such as water molecules, was removed from the BSA structure. The BSA structure and compound were changed by adding the polar hydrogens. Also, the Kollman charges as well as Gasteiger charges were added to the receptor and ligand, respectively. After attaining the pdbqt files of BSA and rifampicin, drug was inputted in determined six different binding sites of BSA. The grid box dimension size at grid points in directions were set to 27 Å with a grid spacing of 1 Å in Vina docking. The energy range and exhaustiveness value were set to and 40, respectively. 3.Results and Discussion3.1.Bovine Serum Albumin ImmobilizationFigure 2 shows the schematic illustration of BSA immobilization on the Au chip surface. The initial curve of the aforementioned process before and after BSA immobilization was shown in Fig. 3. The blue curve shows channel 1, in which BSA has been immobilized and showed angle shift around 0.98 deg. The resonance curves shift to higher incident angles and become wider due to new layer formation on Au sensor slide and increase in the thickness of the adsorbed layer on the surface. From the aforementioned results, it can be concluded that the BSA attachment was performed properly on the Au sensor slide through covalent amide bond formation.17 3.2.Kinetics Binding of Bovine Serum Albumin and RifamipcinThe interaction between the analyte () and the immobilized BSA () can be demonstrated through simple Langmuirian mode of binding for complex formation (). For reversible associations and dissociations in a chemical equilibrium, it can be defined by the following equation:17 where is the association rate constant and is the dissociation rate constant. To attain the kinetic features, calculation of the and rate constants and the equilibrium constants () for the bindings of BSA to rifampicin is required.17,18 The is a measure of ligand affinity to various biomacromolecules, such as BSA and defined as . Figure 4 shows the SPR sensorgrams of the reaction between BSA and rifampicin after reference subtraction at concentrations ranging from 1 to at four temperatures (298, 303, 308, and 313 K).Table 1 shows values of kinetic parameters at four temperatures. According to the Table 1, and of BSA interaction with rifampicin decreased regularly upon rising temperature. It shows that high temperature led in the reaction rate decrease. The mean for rifampicin binding increased almost 2.30 from 15 to over this temperature range. The temperature dependence of the was due to an increase in the value rather than the value. About 15-fold increase in the value was observed when temperature increased from 298 to 313 K. However, there was only sixfold increase in the value when temperature rose to 313 K. As it is clear in Table 1, of BSA interaction with rifampicin increased upon rising temperature, which showed that affinity between two materials decreases upon rising temperatures. Table 1Association rate constant (ka), dissociation rate constant (kd), and equilibrium constants (kD) values of rifampicin interaction with BSA.
3.3.Thermodynamic Parameters Analysis of Binding Bovine Serum Albumin with RifampicinTo investigate the effect of temperature and thermodynamic features, the reaction between BSA and rifampicin was carried out at different temperatures. The type of interaction between BSA protein and rifampicin may consist of the following forces: hydrogen bond, Van der Waals, electrostatic, and hydrophobic forces. The value of thermodynamic parameters, such as enthalpy change () and entropy change (), is used for the estimation of interaction types. The positive value of and shows that the hydrophobic forces play major roles in the binding of two molecules; the negative values represent Van der Waals interactions and hydrogen bonds occurring and finally, the negative value of and positive amount of is indicative of electrostatic interaction happening. These parameters can be calculated through the van’t Hoff Eq. (1) by the plot of ln versus 19 where and are the universal gas constant and temperature, respectively.BSA binding study was performed at four different temperatures (298, 303, 308, and 313 K). Figure 5 shows the plot of ln versus . The total energy released by the reaction is calculated with the Gibbs–Helmholtz The positive values have been attained for both and according to Table 2 for the binding of BSA to rifampicin, which indicates that the binding processes are mainly enthalpy-driven and the rifampicin–BSA interaction can be explained in terms of hydrophobic forces. Although Yu et al7 showed that electrostatic interactions play a major role in the BSA binding to rifampicin using fluorescence spectroscopy; according to some other authors,6 the interaction between rifampicin and BSA occurs through hydrophobic binding processes. Taking into account the lipophilicity of rifampicin, the involvement of the latter forces in the binding process of this drug with BSA seems to be more logical. In addition, the positive value of means that the binding process was nonspontaneous and enthalpy driven and the formation of rifampicin–BSA complex was an endothermic process.2,20,21Table 2Thermodynamic parameters of BSA binding with rifampicin at four different temperatures (298, 303, 308, and 313 K).
3.4.Molecular Docking StudyTwenty mode runs were defined in our docking procedure. After molecular docking process, the best conformation of each rifampicin–BSA complexes relative to the lowest free binding energy () according to the Vina cluster was selected and summarized in Table 3 and the lowest free binding energy conformer of docking for each binding site has been shown in Fig. 6. The lowest free binding energy () for the sites and of albumin molecule was found and presented in Table 3. The subdomain IIB and IIA of albumin molecule has some amino acids with functional groups that can make hydrogen binding as well (Fig. 7). Our docking analysis revealed some H-bondings between rifampicin and BSA (Table 4). Rifampicin has also several functional groups, such as hydroxyl with hydrogen binding capability. Therefore, the possibility of some hydrogen bindings between rifampicin and BSA cannot be totally excluded, although based on the results obtained from thermodynamic studies, this is the hydrophobic forces that act as the major driven forces in the interaction of rifampicin with the protein. Therefore, it seems that rifampicin interacts with BSA through hydrophobic interactions as the major driven forces.1,21 Table 3The lowest binding free energy values (ΔG) calculated by Auto Dock Vina from rifampicin docking with six different binding sites of BSA.
Table 4Amino acids that contacted with rifampicin from the analyzing of all runs of each docking procedure and the number and type of amino acids that join together in formation of H-bond in selected binding site of BSA (IIA and IIB). The number of phrases indicated the repeating of H-bonding with dependent amino acid.
4.ConclusionIn this paper, we studied the interaction between BSA and rifampicin using SPR method and molecular docking analysis. The experimental results revealed that BSA has high affinity to rifampicin, which confirmed with low value of . However, of BSA interaction with rifampicin increased upon rising temperature, which showed that affinity between two material decreases upon rising temperatures. The results of thermodynamic parameters showed that the main force between rifampicin and BSA is hydrophobic due to the hydrophobic nature of drug. Also positive value of confirmed that the binding between BSA and rifampicin is enthalpy-driven and nonspontaneous. In addition, molecular docking study showed the involvement of hydrogen binding in the formation of rifampicin-BSA complex. AcknowledgmentsThe authors are grateful for financial support from the Student Research Committee and Research Center for Pharmaceutical Nanotechnology, Tabriz University of Medical Sciences. ReferencesD. Agudelo et al.,
“Probing the binding sites of antibiotic drugs doxorubicin and N-(trifluoroacetyl) doxorubicin with human and bovine serum albumins,”
PLoS One, 7
(8), e43814
(2012). http://dx.doi.org/10.1371/journal.pone.0043814 POLNCL 1932-6203 Google Scholar
A. Belatik et al.,
“Binding sites of retinol and retinoic acid with serum albumins,”
Eur. J. Med. Chem., 48 114
–123
(2012). http://dx.doi.org/10.1016/j.ejmech.2011.12.002 Google Scholar
A. Belatik et al.,
“Locating the binding sites of Pb(II) ion with human and bovine serum albumins,”
PLoS One, 7
(5), e36723
(2012). http://dx.doi.org/10.1371/journal.pone.0036723 POLNCL 1932-6203 Google Scholar
J. S. Mandeville and H. A. Tajmir-Riahi,
“Complexes of dendrimers with bovine serum albumin,”
Biomacromolecules, 11
(2), 465
–472
(2010). http://dx.doi.org/10.1021/bm9011979 BOMAF6 1525-7797 Google Scholar
J. Flarakos, K. L. Morand and P. Vouros,
“High-throughput solution-based medicinal library screening against human serum albumin,”
Anal. Chem., 77
(5), 1345
–1353
(2005). http://dx.doi.org/10.1021/ac048685z ANCHAM 0003-2700 Google Scholar
B. P. Kamat and J. Seetharamappa,
“Mechanism of interaction of vincristine sulphate and rifampicin with bovine serum albumin: a spectroscopic study,”
J. Chem. Sci., 117
(6), 649
–655
(2005). http://dx.doi.org/10.1007/BF02708294 Google Scholar
O.-Y. Yu et al.,
“Probing the binding of rifampicin to bovine serum albumin in aqueous solution,”
J. Solution Chem., 40
(10), 1711
–1723
(2011). http://dx.doi.org/10.1007/s10953-011-9747-6 JSLCAG 0095-9782 Google Scholar
M. S. Benedetti and P. Dostert,
“Induction and autoinduction properties of rifamycin derivatives: a review of animal and human studies,”
Environ. Health Perspect., 102
(Suppl. 9), 101
–105
(1994). http://dx.doi.org/10.1289/ehp.94102s9101 EVHPAZ 0091-6765 Google Scholar
A. Tupin et al.,
“Resistance to rifampicin: at the crossroads between ecological, genomic and medical concerns,”
Int. J. Antimicrob. Agents, 35
(6), 519
–523
(2010). http://dx.doi.org/10.1016/j.ijantimicag.2009.12.017 IAAGEA Google Scholar
R. J. Green et al.,
“Surface plasmon resonance analysis of dynamic biological interactions with biomaterials,”
Biomaterials, 21
(18), 1823
–1835
(2000). http://dx.doi.org/10.1016/S0142-9612(00)00077-6 BIMADU 0142-9612 Google Scholar
R. L. Rich and D. G. Myszka,
“Advances in surface plasmon resonance biosensor analysis,”
Curr. Opin. Biotechnol., 11
(1), 54
–61
(2000). http://dx.doi.org/10.1016/S0958-1669(99)00054-3 CUOBE3 0958-1669 Google Scholar
J. Homola,
“Surface plasmon resonance sensors for detection of chemical and biological species,”
Chem. Rev., 108
(2), 462
–493
(2008). http://dx.doi.org/10.1021/cr068107d CHREAY 0009-2665 Google Scholar
D. G. Myszka and R. L. Rich,
“Implementing surface plasmon resonance biosensors in drug discovery,”
Pharm. Sci. Technol. Today, 3
(9), 310
–317
(2000). http://dx.doi.org/10.1016/S1461-5347(00)00288-1 Google Scholar
J. M. McDonnell,
“Surface plasmon resonance: towards an understanding of the mechanisms of biological molecular recognition,”
Curr. Opin. Chem. Biol., 5
(5), 572
–577
(2001). http://dx.doi.org/10.1016/S1367-5931(00)00251-9 COCBF4 1367-5931 Google Scholar
O. Trott and A. J. Olson,
“AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization and multithreading,”
J. Comput. Chem., 31
(2), 455
–461
(2010). http://dx.doi.org/10.1002/jcc.21334 JCCHDD 0192-8651 Google Scholar
J. J. P. Stewart,
“Optimization of parameters for semiempirical methods I. Method,”
J. Comput. Chem., 10
(2), 209
–220
(1989). http://dx.doi.org/10.1002/(ISSN)1096-987X JCCHDD 0192-8651 Google Scholar
F. Fathi et al.,
“Kinetic studies of bovine serum albumin interaction with PG and TBHQ using surface plasmon resonance,”
Int. J. Biol. Macromol., 91 1045
–1050
(2016). http://dx.doi.org/10.1016/j.ijbiomac.2016.06.054 IJBMDR 0141-8130 Google Scholar
M. Ehteshami et al.,
“Characterization of 6-mercaptopurine binding to bovine serum albumin and its displacement from the binding sites by quercetin and rutin,”
J. Lumin., 135 164
–169
(2013). http://dx.doi.org/10.1016/j.jlumin.2012.10.044 JLUMA8 0022-2313 Google Scholar
Y. S. N. Day et al.,
“Direct comparison of binding equilibrium, thermodynamic, and rate constants determined by surface- and solution-based biophysical methods,”
Protein Sci.: Publ. Protein Soc., 11
(5), 1017
–1025
(2002). http://dx.doi.org/10.1110/(ISSN)1469-896X Google Scholar
F. Rasoulzadeh et al.,
“Fluorescence quenching study of quercetin interaction with bovine milk xanthine oxidase,”
Spectrochim. Acta, Part A, 72
(1), 190
–193
(2009). http://dx.doi.org/10.1016/j.saa.2008.09.021 Google Scholar
J. E. N. Dolatabadi et al.,
“Spectroscopic and molecular modeling studies of human serum albumin interaction with propyl gallate,”
RSC Adv., 4
(110), 64559
–64564
(2014). http://dx.doi.org/10.1039/C4RA11103F Google Scholar
|